CHIKV an infection leads to MCP-induced cellular infiltration inside the inflamed joints, and bone loss may be ameliorated by treatment method using an MCP-inhibiting drug, bindarit. Taken collectively, our info expose a Formerly undescribed position for MCPs in CHIKV-induced bone loss: one of recruiting monocytes/OC precursors to joint sites and https://luisl998epz1.blogs100.com/profile